Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance

Details for Australian Patent Application No. 2003247777 (hide)

Owner Wayne State University

Inventors Cunningham, Phillip R.

Agent Watermark

Pub. Number AU-B-2003247777

PCT Number PCT/US03/20963

PCT Pub. Number WO2004/003511

Priority 60/393,237 01.07.02 US; 60/452,012 05.03.03 US

Filing date 1 July 2003

Wipo publication date 19 January 2004

Acceptance publication date 18 September 2008

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 15/70 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for E. coli

C12P 21/00 (2006.01) Preparation of peptides or proteins

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

Event Publications

2 October 2003 Complete Application Filed

  Priority application(s): 60/393,237 01.07.02 US; 60/452,012 05.03.03 US

4 March 2004 Application Open to Public Inspection

  Published as AU-B-2003247777

18 September 2008 Application Accepted

  Published as AU-B-2003247777

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003247778-CASPASE 9 ACTIVATION AND USES THEREFOR

2003247776-NUCLEIC ACID MOLECULES ENCODING SERINE PROTEASE 16, THE ENCODED POLYPEPTIDES AND METHODS BASED THEREON